用放射性碘治疗高甲状腺球蛋白：是神奇子弹还是盲目尝试？ - Suppr

Suppr

超能文献

Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark?

作者信息

Mazzaferri E L

出版信息

J Clin Endocrinol Metab. 1995 May;80(5):1485-7. doi: 10.1210/jcem.80.5.7744990.

DOI:10.1210/jcem.80.5.7744990

PMID:7744990

Abstract

摘要

相似文献

Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark?用放射性碘治疗高甲状腺球蛋白：是神奇子弹还是盲目尝试？

J Clin Endocrinol Metab. 1995 May;80(5):1485-7. doi: 10.1210/jcem.80.5.7744990.

Should high hTg levels in the absence of iodine uptake be treated?

Eur J Nucl Med Mol Imaging. 2003 May;30(5):794-5. doi: 10.1007/s00259-003-1139-8. Epub 2003 Mar 4.

Should high hTg levels in the absence of iodine uptake be treated?在无碘摄取情况下高甲状腺球蛋白（hTg）水平是否应予以治疗？

Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):160-3. doi: 10.1007/s00259-002-1004-1.

Should high hTg levels in the absence of iodine uptake be treated?在没有碘摄取的情况下，高甲状腺球蛋白（hTg）水平是否应该接受治疗？

Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):157-60. doi: 10.1007/s00259-002-1003-2.

[Postoperative follow-up in differentiated carcinoma of the thyroid gland].[甲状腺分化型癌的术后随访]

Minerva Med. 1986 Jun 30;77(27):1317-9.

Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.碘-131治疗甲状腺球蛋白升高且诊断性扫描阴性的甲状腺癌患者。

J Clin Endocrinol Metab. 1995 May;80(5):1488-92. doi: 10.1210/jcem.80.5.7744991.

Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.甲状腺过氧化物酶：分化型甲状腺癌治疗后随访的肿瘤标志物？一项时间进程研究的结果

Cancer Detect Prev. 2000;24(6):524-30.

Role of FDG PET in metastatic thyroid cancer.氟代脱氧葡萄糖正电子发射断层扫描在转移性甲状腺癌中的作用。

J Nucl Med. 1999 Jun;40(6):993-4.

Thyroglobulin-positive, radioiodine-negative thyroid cancer.甲状腺球蛋白阳性、放射性碘阴性的甲状腺癌。

Thyroid. 2001 Jun;11(6):599-602. doi: 10.1089/105072501750302921.

Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer.罗格列酮治疗甲状腺球蛋白阳性且放射性碘阴性的晚期分化型甲状腺癌患者的疗效

Thyroid. 2009 Sep;19(9):953-6. doi: 10.1089/thy.2008.0371.

引用本文的文献

Practice trends in patients with persistent detectable thyroglobulin and negative diagnostic radioiodine whole body scans: a survey of American Thyroid Association members.持续性可检测到甲状腺球蛋白且诊断性放射性碘全身扫描阴性患者的诊疗趋势：美国甲状腺协会成员调查

Thyroid. 2014 Oct;24(10):1501-7. doi: 10.1089/thy.2014.0043. Epub 2014 Sep 5.

Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm.对于经适当选择的原发性肿瘤大于1厘米的分化型甲状腺癌患者，甲状腺叶切除术具有良好的临床效果。

J Thyroid Res. 2013;2013:398194. doi: 10.1155/2013/398194. Epub 2013 Dec 23.

Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer.分化型甲状腺癌患者血清甲状腺球蛋白升高且诊断性放射性碘全身扫描阴性的长期病程及预测因素

J Endocrinol Invest. 2005 Jun;28(6):540-6. doi: 10.1007/BF03347243.

I-131 therapy for thyroglobulin positive patients without anatomical evidence of persistent disease.

J Endocrinol Invest. 2004 Nov;27(10):949-53. doi: 10.1007/BF03347538.

Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer.

World J Surg. 2004 Nov;28(11):1110-4. doi: 10.1007/s00268-004-7636-5.

Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases.碘阴性、甲状腺球蛋白阳性甲状腺癌的治疗：大转移灶患者与微转移灶患者的预后差异。

Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1500-4. doi: 10.1007/s00259-004-1516-y. Epub 2004 Jul 1.

Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.为期三周的甲状腺素撤药甲状腺球蛋白刺激筛查试验，用于检测低风险残留/复发性高分化甲状腺癌。

J Endocrinol Invest. 2003 Oct;26(10):1023-31. doi: 10.1007/BF03348202.

Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer.颈淋巴结清扫术对TG阳性、放射性碘全身扫描阴性的复发性/持续性乳头状甲状腺癌患者血清TG及病程的影响

J Endocrinol Invest. 2002 Jun;25(6):526-31. doi: 10.1007/BF03345495.

Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer.全甲状腺切除术即使对高危分化型甲状腺癌患者也不能提高疾病控制率或生存率。

Ann Surg. 1998 Jun;227(6):912-21. doi: 10.1097/00000658-199806000-00015.

The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer.血清甲状腺球蛋白在分化型甲状腺癌随访中的预测价值。

Eur J Nucl Med. 1997 Jul;24(7):722-7. doi: 10.1007/BF00879658.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验